Cantor Fitzgerald analyst Steven Halper views share weakness in Allscripts (NASDAQ: MDRX) as overdone. The analyst reiterated an Overweight ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE